| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| meta-analysis | Q815382 |
| P2093 | author name string | Yuan Lin | |
| Tao Tang | |||
| Cong Wang | |||
| A-Li Yang | |||
| Han-Jin Cui | |||
| Hua-Jun Zhou | |||
| Jie-Kun Luo | |||
| Hao-yu He | |||
| P2860 | cites work | Iron chelators for acute stroke | Q24200865 |
| Preclinical and clinical research on inflammation after intracerebral hemorrhage | Q24594191 | ||
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Progression of mass effect after intracerebral hemorrhage | Q28198134 | ||
| (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways | Q28238366 | ||
| Iron Toxicity in Mice with Collagenase-Induced Intracerebral Hemorrhage | Q28299109 | ||
| Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage | Q28582035 | ||
| Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats | Q33418203 | ||
| Recommendations for standards regarding preclinical neuroprotective and restorative drug development | Q33785562 | ||
| Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits | Q80837138 | ||
| Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration | Q33957924 | ||
| Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review | Q34392812 | ||
| Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model | Q34520694 | ||
| Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke | Q34598105 | ||
| Progesterone for the treatment of experimental brain injury; a systematic review | Q34666646 | ||
| Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality | Q34797518 | ||
| Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury | Q35577480 | ||
| Treatment targets in intracerebral hemorrhage | Q35648063 | ||
| Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 mice | Q35783263 | ||
| Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
| Estrogens and experimental ischemic stroke: a systematic review | Q36377761 | ||
| Delays in hospital admission and investigation in acute stroke | Q36904287 | ||
| Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron | Q37113448 | ||
| Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. | Q37262595 | ||
| Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials | Q37344139 | ||
| Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome. | Q37360337 | ||
| High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods | Q37598917 | ||
| Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats | Q39933492 | ||
| Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage | Q40121434 | ||
| Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model | Q41862254 | ||
| Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products | Q42170839 | ||
| Iron and iron-handling proteins in the brain after intracerebral hemorrhage. | Q42452709 | ||
| Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats | Q42464660 | ||
| Deferoxamine reduces cavity size in the brain after intracerebral hemorrhage in aged rats | Q42490977 | ||
| Phenobarbital augments hypothermic neuroprotection. | Q42725654 | ||
| Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study | Q43012682 | ||
| Poly(ADP-ribose) polymerase activation and brain edema formation by hemoglobin after intracerebral hemorrhage in rats. | Q46208644 | ||
| Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. | Q46234110 | ||
| Long-term effects of experimental intracerebral hemorrhage: the role of iron | Q46969940 | ||
| Iron-related brain damage in patients with intracerebral hemorrhage | Q48292711 | ||
| Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass | Q48355258 | ||
| Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. | Q48557260 | ||
| Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage | Q48935887 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | carboxylic acid | Q134856 |
| bleeding | Q166019 | ||
| amine | Q167198 | ||
| cerebral hemorrhage | Q1368943 | ||
| systematic review | Q1504425 | ||
| mechanism of action | Q3271540 | ||
| deferoxamine | Q419618 | ||
| meta-analysis | Q815382 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0127256 | |
| P577 | publication date | 2015-05-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Efficacy of deferoxamine in animal models of intracerebral hemorrhage: a systematic review and stratified meta-analysis | |
| P478 | volume | 10 |
| Q28067212 | A Review on Iron Chelators in Treatment of Iron Overload Syndromes |
| Q41678608 | Brain iron overload following intracranial haemorrhage |
| Q47723442 | Challenges for intraventricular hemorrhage research and emerging therapeutic targets |
| Q64228674 | Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis |
| Q91976165 | Deferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage |
| Q53276190 | Deferoxamine therapy for intracerebral hemorrhage: A systematic review. |
| Q64285923 | Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron |
| Q92023336 | Ferroptosis and Brain Injury |
| Q98226249 | Ferroptosis in Acute Central Nervous System Injuries: The Future Direction? |
| Q39268424 | Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage |
| Q26748764 | Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy |
| Q90286774 | Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention |
| Q41531083 | Management of Spontaneous Intracerebral Hemorrhage |
| Q46362006 | Neuroprotection of brain-permeable iron chelator VK-28 against intracerebral hemorrhage in mice |
| Q26769071 | Oxidative Stress in Intracerebral Hemorrhage: Sources, Mechanisms, and Therapeutic Targets |
| Q34524885 | Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice |
| Q38750412 | Programmed Cell Death after intracerebral hemorrhage. |
| Q38841916 | Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage |
| Q64080506 | Targeting GPER1 to suppress autophagy as a male-specific therapeutic strategy for iron-induced striatal injury |
| Q48908160 | Treatment of Edema Associated With Intracerebral Hemorrhage |
| Q88617261 | Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma |
Search more.